Genetics Generation Advancement Corp. (TPEX:4160)

TPEX:4160 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	83.53	65.67	129	128.48	57.45	85.28
Short-Term Investments	204.07	310.49	243.15	150.32	155.76	81.73
Trading Asset Securities	31.63	31.21	40.75	35.41	44.4	31.93
Cash & Short-Term Investments	319.23	407.37	412.9	314.21	257.61	198.94
Cash Growth	-2.03%	-1.34%	31.41%	21.97%	29.49%	-4.61%
Accounts Receivable	120.4	125.29	101.56	99.37	98.58	81.2
Other Receivables	7.19	3.12	1.46	1.72	1.74	2.52
Receivables	127.59	128.4	103.02	101.09	100.32	83.72
Inventory	58.25	71.24	34.98	34.8	31.29	59.71
Prepaid Expenses	11.84	9.36	7.31	4.16	6.75	14.66
Other Current Assets	1.59	1.58	1.59	2.33	3.38	2.35
Total Current Assets	518.5	617.96	559.79	456.58	399.35	359.37
Property, Plant & Equipment	78.83	61.57	48.74	37.45	23.77	22.83
Long-Term Investments	80.66	88.23	85.56	72.96	-	-
Goodwill	10.09	10.09	10.09	10.09	10.09	10.09
Other Intangible Assets	13.92	13.84	9.48	11.9	13.77	16.41
Long-Term Deferred Tax Assets	2	2.14	2.15	2.28	5.09	12
Other Long-Term Assets	13.87	12.24	8.51	3.8	3.59	4.06
Total Assets	717.86	806.05	724.3	595.05	455.66	424.76

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	41.14	54.8	43.68	43.92	41.52	38.86
Accrued Expenses	38.34	47.74	56.1	50.05	44.71	34.25
Short-Term Debt	100	70	30	30	-	-
Current Portion of Leases	9.41	4.46	7.97	8.11	0.76	0.46
Current Income Taxes Payable	0.78	-	10.84	3.12	-	1.46
Current Unearned Revenue	10.9	8.71	10.19	8.22	9.98	21.48
Other Current Liabilities	7.06	13.62	9.67	11.15	9.26	7.65
Total Current Liabilities	207.64	199.33	168.43	154.56	106.22	104.15
Long-Term Leases	16.56	4.72	2.38	10.35	1.74	1.91
Long-Term Deferred Tax Liabilities	-	-	-	-	0.25	-
Total Liabilities	224.2	204.05	170.81	164.91	108.2	106.06

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	266.9	266.9	266.9	254.05	242.47	242.47
Additional Paid-In Capital	55.29	55.29	55.29	46.09	45.13	45.13
Retained Earnings	63.04	69.9	97.83	36.53	31.13	12.45
Comprehensive Income & Other	107.84	209.46	133.1	93.28	28.74	18.87
Total Common Equity	493.08	601.56	553.13	429.94	347.46	318.92
Minority Interest	0.59	0.45	0.36	0.2	-0	-0.22
Shareholders' Equity	493.67	602	553.49	430.15	347.46	318.7
Total Liabilities & Equity	717.86	806.05	724.3	595.05	455.66	424.76

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	125.97	79.19	40.35	48.46	2.49	2.37
Net Cash (Debt)	193.25	328.18	372.56	265.75	255.12	196.57
Net Cash Growth	-38.34%	-11.91%	40.19%	4.17%	29.79%	-5.72%
Net Cash Per Share	7.23	12.27	13.89	9.91	9.50	7.35
Filing Date Shares Outstanding	26.69	26.96	26.69	26.69	26.69	26.69
Total Common Shares Outstanding	26.69	26.96	26.69	26.69	26.69	26.69
Working Capital	310.86	418.63	391.36	302.02	293.13	255.22
Book Value Per Share	18.47	22.31	20.72	16.11	13.02	11.95
Tangible Book Value	469.07	577.63	533.56	407.95	323.6	292.42
Tangible Book Value Per Share	17.57	21.43	19.99	15.28	12.12	10.96
Machinery	119.01	110.59	87.83	62.64	61.05	53.98
Leasehold Improvements	5.35	5.35	2.52	2.14	1.48	1.48

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 8, 2026

Data Sources Report a data error